Literature DB >> 17962169

Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies.

Joanne Lester1.   

Abstract

Research continues to advance breast health practices, risk assessment, risk reduction strategies, and early detection of breast cancer. Nurses must maintain a current knowledge base to appropriately screen, educate, and counsel women in their fight against the number-one cause of cancer in women and the second-largest source of cancer death in women in the United States (Jemal et al., 2007).

Entities:  

Mesh：

Year:  2007        PMID： 17962169     DOI： 10.1188/07.CJON.619-622

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN： 1092-1095            Impact factor:   1.027


  15 in total

Review 1.  Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.

Authors:  Richard Marcotte; William J Muller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-24       Impact factor: 2.673

2.  Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells.

Authors:  Hannah Schmucker; Walker M Blanding; Julia M Mook; Jessica F Wade; Jang Pyo Park; Kerri Kwist; Hiral Shah; Brian W Booth
Journal:  Cell Oncol (Dordr)       Date:  2017-11-27       Impact factor: 6.730

3.  CD243 gene polymorphism significantly associated with breast cancer susceptibility.

Authors:  Weirong Yao; Rongzeng Yan; Lin Ma; Huiping Wan; Yanmin Yu; Xia Cheng; Yingliang Li
Journal:  Tumour Biol       Date:  2014-05-18

4.  Validation of an in vitro model of erbB2(+) cancer cell redirection.

Authors:  Jang Pyo Park; Walker M Blanding; Jessica A Feltracco; Brian W Booth
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-04-22       Impact factor: 2.416

5.  A Study on the Knowledge, Perception, and Use of Breast Cancer Screening Methods and Quality of Care Among Women from Central Mexico.

Authors:  Andrea B Cruz-Castillo; María A Hernández-Valero; Shelly R Hovick; Martha Elva Campuzano-González; Miguel Angel Karam-Calderón; L Patricia Bustamante-Montes
Journal:  J Cancer Educ       Date:  2015-09       Impact factor: 2.037

Review 6.  Toremifene in the treatment of breast cancer.

Authors:  Mika Vj Mustonen; Seppo Pyrhönen; Pirkko-Liisa Kellokumpu-Lehtinen
Journal:  World J Clin Oncol       Date:  2014-08-10

7.  Why do breast cancer patients report late or abscond during treatment in ghana? A pilot study.

Authors:  J Clegg-Lamptey; J Dakubo; Y N Attobra
Journal:  Ghana Med J       Date:  2009-09

Review 8.  Mouse modifier genes in mammary tumorigenesis and metastasis.

Authors:  Scott F Winter; Kent W Hunter
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-07-26       Impact factor: 2.673

9.  Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy.

Authors:  M Carla Zimmermann; Syreeta L Tilghman; Stephen M Boué; Virgilio A Salvo; Steven Elliott; K Y Williams; Elena V Skripnikova; Hasina Ashe; Florastina Payton-Stewart; Lyndsay Vanhoy-Rhodes; Juan Pablo Fonseca; Cynthia Corbitt; Bridgette M Collins-Burow; Melanie H Howell; Michelle Lacey; Betty Y Shih; Carol Carter-Wientjes; Thomas E Cleveland; John A McLachlan; Thomas E Wiese; Barbara S Beckman; Matthew E Burow
Journal:  J Pharmacol Exp Ther       Date:  2009-10-01       Impact factor: 4.030

10.  Profile of Breast Diseases in Post Pubertal Women Assessed By Clinical Breast Examination - A Community Based Study in Rural Pondicherry.

Authors:  Kavasseri L Janaki; Narayanasamy Subbaraju Kannan; M Palaniappan; Partha Nandi
Journal:  J Clin Diagn Res       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.